| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |